{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:01:28Z","timestamp":1790625688907,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.livres.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:42:30Z","timestamp":1785368550000},"page":"260-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond symptom relief: The promise of Linerixibat as a mechanism-based therapy for cholestatic pruritus in primary biliary cholangitis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4197-2153","authenticated-orcid":false,"given":"Muhammad Hamza","family":"Ameer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Areeb ul Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0965-2442","authenticated-orcid":false,"given":"Menahal","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Zia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4643-4820","authenticated-orcid":false,"given":"Amna","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"744.e1","DOI":"10.1016\/j.amjmed.2017.01.037","article-title":"Management of pruritus in primary biliary cholangitis: a narrative review","volume":"130","author":"Trivedi","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.livres.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaad.2019.04.035","article-title":"Cholestatic pruritus: emerging mechanisms and therapeutics","volume":"81","author":"Patel","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.livres.2026.07.002_bib3","unstructured":"GlaxoSmithKline. LYNAVOY (Linerixibat) Tablets: Prescribing Information. GlaxoSmithKline; 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2026\/220295Orig1s000lbl.pdf. Accessed 2 July 2026."},{"key":"10.1016\/j.livres.2026.07.002_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231172829","article-title":"Systematic review: efficacy of therapies for cholestatic pruritus","volume":"16","author":"Ebhohon","year":"2023","journal-title":"Therapeut Adv Gastroenterol"},{"key":"10.1016\/j.livres.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.cgh.2022.10.032","article-title":"GLIMMER: a randomized phase 2b dose-ranging trial of Linerixibat in primary biliary cholangitis patients with pruritus","volume":"21","author":"Levy","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1124\/dmd.121.000595","article-title":"Pharmacokinetics and ADME characterization of intravenous and oral [14C]-Linerixibat in healthy male volunteers","volume":"49","author":"Zamek-Gliszczynski","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.livres.2026.07.002_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2468-1253(25)00192-X","article-title":"Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Hirschfield","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568426000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:28:26Z","timestamp":1790623706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568426000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2542568426000401"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2026.07.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond symptom relief: The promise of Linerixibat as a mechanism-based therapy for cholestatic pruritus in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}